
Journal of Physical Chemistry p. 2505 - 2509 (1992)
Update date:2022-08-22
Topics:
Oxley, J. C.
Hiskey, M.
Naud, D.
Szekeres, R.
Kinetics and activation parameters of the solution thermolysis of nitramines dimethylnitramine, diisopropylnitramine, and N-nitropiperidine were determined over the temperature range 200-300 deg C.Each formed the corresponding nitrosamine as the only, or major, condensed-phase product.For dimethylnitramine the products were completely characterized.The observations of a large positive activation volume in the thermolysis of dimethylnitramine and of the slowing of the decomposition reaction with increased solvent viscosity both suggest that the rate-determining step is homolysis, the N-NO2 bond being the most obvious point for this.Nitrosamines could be produced by this route; however, when doubly 15N-labeled dimethylnitramine was heated with unlabeled dimethylnitramine, little scrambling of the label in the reactant was observed.Label scrambling was observed in the nitrosamine but could have resulted from subsequent N-NO homolysis.Scrambling of the label in the product gases and the observation of a kinetic isotope effect when perdeuterated dimethylnitramine was decomposed were explained in terms of a second decomposition route involving transfer of hydrogen from the α carbon to one of the NO2 oxygens.
View More
Suzhou Howsine Biological Technology Co.,Ltd(expird)
website:http://www.howsine.com
Contact:86-512-67262751
Address:No 3,Weihua Road ,Suzhou Industrial Park ,Jiangsu ,China.
ShangHai Soyoung Biotechnology Inc
website:http://www.soyoungbio.com
Contact:+86-21-69893009
Address:shanghai
AUSHUN PHARMACEUTICAL TECHNOLOGY CO,.LTD
Contact:+86-25-86883560 15951806178
Address:14 Dayingbi, Zhujiang Rd. East, Nanjing, Jiangsu, China.
website:http://www.eastarchem.com/
Contact:1-800-898-2436
Address:1215 K Street, STE 1700
Improve Medical Technology(Nanxiong) Co., Ltd
Contact:86-751-3836997
Address:No.33, Pingan First Road, Fine Chemical Industry Base, Nanxiong City, Shaoguan, Guangdong, China
Doi:10.1002/ejic.202000790
(2021)Doi:10.1055/s-2005-918483
(2005)Doi:10.1016/S0022-328X(97)00757-2
(1998)Doi:10.1021/acs.molpharmaceut.9b00181
(2019)Doi:10.1039/b413132k
(2005)Doi:10.1038/138121a0
(1936)